Nynomic (M7U) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
31 Aug, 2026Company profile and structure
Over 30 years of innovation in optical measurement technology, employing around 500 people, with about 30% being engineers and scientists.
Headquarters located in Wedel, Northern Germany, and listed on the stock exchange since 2007.
Operates as a strategic financial holding with a portfolio of powerful brands focused on non-contact, non-destructive optical measurement.
Vertically integrated, offering solutions from components to complete systems across multiple subsidiaries.
Financial performance and guidance
Revenue for HY 2026 reached €47.7M, up 13% from HY 2025, with EBIT turning positive at €1.8M.
EBIT margin improved to 3.8% from -4.8%, and cash increased by 18% to €12.3M.
Orders on hand rose 46% to €63.5M, supporting a positive outlook for the remainder of 2026.
2026 revenue guidance is €100–105M, with sustainable annual growth of 10% expected.
EBIT margin for 2026 projected at 6–8%, with steady increases anticipated in coming years.
Market focus and growth drivers
Clean tech, especially the semiconductor sector, is identified as the dominant growth segment.
Growth in gas measurement driven by rising energy demand and AI-related applications.
Process measurement expected to grow in line with the broader photonics industry.
Key applications include semiconductor front-end processes, energy supply, and automation.
Latest events from Nynomic
- Revenue up 13% and EBIT positive in H1 2026; guidance for strong full-year growth confirmed.M7U
H1 2026 - Revenue and EBIT fell in 2025, but efficiency measures and a strong order backlog support a positive 2026 outlook.M7U
H2 2025 - 2025 saw a revenue dip, but Q1 2026 growth and cost savings signal a strong recovery.M7U
AGM 2026 presentation - Stable margins and growing order backlog offset lower sales, supporting a strong H2 outlook.M7U
H1 2024 - Revenue and EBIT declined sharply, but strong order backlog and equity ratio support 2025 growth.M7U
H2 2024 - Revenue down 12% and EBIT negative in H1 2025; outlook revised amid ongoing market challenges.M7U
H1 2025